Cancer-related fatigue,CRF
Conditions
Interventions
Test group:Administer de-husked Ganoderma lucidum spore powder orally.
Control group:Give oral placebo
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with cancer through pathological examination and undergoing radiotherapy for 4-6 weeks; 2. 18 years of age or older; 3. Cancer Fatigue Revised Scale total score > 0, indicating fatigue; 4. Normal language communication and reading abilities; 5. Expected survival >= 6 months; 6. Agree and willing to actively cooperate with the trial;
Exclusion criteria
Exclusion criteria: 1. Patients with allergic constitutions and patients with known or suspected allergies to investigational drugs; 2. Individuals with a history of or current mental symptoms and impaired consciousness, memory, comprehension, and other cognitive impairments; 3. Those whose general condition is poor and who have discontinued radiotherapy; 4. Non-compliant individuals;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cancer-related fatigue improved; | — |
Secondary
| Measure | Time frame |
|---|---|
| improvement in quality of life;Complete blood count, liver and kidney function, and CRP indicators;Peripheral blood serum cytokines; | — |
Countries
China
Contacts
Public ContactZhu Ning
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed